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INTRODUCTION
Mammography can detect non-palpable abnormalities in
over 30% of examined women.1 According to BI-RADS
lexicon mammograms fall into six categories.2
Category-3 mammograms are considered probably-
benign lesions and may either be followed-up3 or
subjected to biopsy.4 The rate of carcinoma being
diagnosed in non-palpable lesions, detected by
mammography, is 11-36%.5 Most biopsies performed
on mammographically detected lesions turn out to be
benign. Attempts, therefore, should be directed to
increase the diagnostic accuracy of mammography to
make the procedure more cost-effective. Many
radiologists will recommend periodic short-term follow-
up of category-3 lesions to reduce the number of
biopsies with negative results, knowingly running the
risk of overlooking 0.5-4% of cancers.6-8 The scientific
evidence establishing the safety and efficacy of
substituting periodic mammographic surveillance for
prompt tissue diagnosis is based on two longitudinal
studies of prospectively identified consecutive cases,
collectively involving more than 80,000 mammography
examinations.9 Results from all over  the globe showed
that the frequency of cancer among probably benign
lesion is less than 2%.1,5,6,8,10-12
There are several reasons to recommend short-term
follow-up of category-3 lesions instead of obtaining
tissue diagnosis. The positive predictive value of biopsy
(whether fine needle aspiration, core and surgical
biopsy) increases with decrease in number of biopsies
for benign lesions.1,5,8,9,13 Follow-up mammography is
associated with reduced morbidity, when compared to
open surgical biopsy,14 as well as image-guided
percutaneous biopsy.15 The cost is also less than open
surgical or image guided biopsy.
Since, there is scarce data regarding the follow-up of
breast lesions  in local setting, this study was conducted
to determine the effectiveness of assigning BI-RADS
category-3 to breast lesion with respect to follow-up in
this study group.
PATIENTS AND METHODS
It was a cohort study conducted at the Radiology
Department of the Aga Khan University Hospital,
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Karachi, from January 2002 to December 2004. Medical
records of 4667 consecutive patients undergoing
mammography for a period of two years were reviewed.
Inclusion criteria were all patients assigned BI-RADS
category-3. Exclusion criteria were non-compliance
for follow-up examination or refusal for biopsy if the
lesion progressed on follow-ups. Mammograms were
performed on Senograph 500 T Senix H.F and
Mammomat 3000 Nova (Siemens). For screening
mammograms, standard cranio caudal and oblique
views were performed. For diagnostic mammograms in
addition to two standard views, additional views such as
spot compression or magnification views, as and when
required,  were done.   Short-term follow-up was defined
as follow-up with X-ray mammography at six monthly
interval and cases were followed for a maximum period
of 1-1/2 years.  All cases in which findings progressed
on 6 months follow-up mammograms underwent biopsy.
Gold standard was either stable morphology on
maximum follow-up, or biopsy. If the findings regressed
or remained stable after 6 months, short-term follow-up
was discontinued and patient was advised screening
after one year as routine, that would be 1 year after the
initial mammograms corresponding to the time for
scheduled screening study after one year. 
Definite diagnosis of the finding on all mammograms,
given category-3, was based on stability or regression
on follow-up mammography after one year, the
histopathological diagnosis of lesions that showed
mammographic progression, and the lesions that were
recommended for observation but instead underwent
biopsy owing to preference of patients or the referring
physician.
RESULTS
A total of 4667 mammograms were performed from
2002 to 2004. Out of those, 116 mammograms were
assigned category-3. Follow-up was available in 65
(56.04%) patients. In 41 patients, no follow-up was
available. Patients who did not turn-up for the 6 monthly
recommended mammograms were excluded from the
study. The mean age of patients was 50.2 years ranging
from 25-74 years.
Among the 65 patients, 55 were true negative as
evidenced by follow-up mammograms in which the
lesion remained stable or regressed. Forty-five out of
55 patients had partly well-defined nodules of 1-2 cm in
size, which remained stable or further regressed in size.
A total of 18 patients had 2 or 3 specks of micro-
calcifications, which either became macro-calcification
or coarse on 6 months follow-up or remained stable.
Remaining 2 patients had scattered and clustered
micro-calcification in both breasts suggestive of
sclerosing adenosis.  
Out of 65 patients, 10  underwent biopsy 2-4 weeks
after the mammograms. Of these 10, 2 patients had
indeterminate punctate type of calcifications, which had
increased in number, and these cases turned out to be
malignant. The remaining 8 patients underwent biopsy
because of clinician or patient’s preference. All 8 had
2-3 punctate micro-calcifications type, which remained
stable mammographically and were histopathologically
reported as benign. The two mammograms, which
were reported to be malignant histopathologically,
turned out to be of ductal carcinoma in situ. Of the
8 benign cases, 5 were reported as sclerosing adenosis,
one each as fibrocystic change, epithelial hyperplasia,
and fibrosclerosis with calcifications, Table I. The overall
sensitivity, specificity, positive and negative predictive
value of assigning category 3 lesions were 100%, 87%,
20% and 100% respectively. 
DISCUSSION
The value of mammography to reduce cancer mortality
in a study population is mainly based on detection of
non-palpable breast lesions. In the Western world, there
is considerable patient awareness regarding breast
cancer and medical expenses including the  cost of
mammography are borne by the State. In Pakistan, no
screening programme for breast cancer is being offered
in the public sector. Patients have to self-bear the
mammography cost. In addition, there is lack of public
awareness and education regarding breast cancer.
Therefore, most of the patients, assigned short-term
follow-up of probably benign breast lesion, do not
turn up for recommended short interval follow-up
examinations. A radiologist assigning category-3 is in a
diagnostic dilemma regarding the outcome on follow-up
mammography, instead of recommending biopsy.
Mammographic follow-up of non-palpable probably
benign lesions detected on mammography, known as
Breast Imaging Reporting and Data System ( BI-RADS)
category-3 lesions is a known strategy to reduce the
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Table I:  Final outcome of patients according to follow-up/biopsy 
results (n=65).
No. of No. of mammograms Final BI-RADS Biopsy/
patients category follow-up results
N=65 Initial examination
Masses/asymmetrical density n= 45 B-3 6-month follow-up
Suspicious micro-calcifications n=20 B-3 6-month follow-up
N=65 6-month follow-up 
Masses/asymmetrical density 
(stable/regressed) n= 45 B-3 1 year follow-up
Suspicious micro-calcifications 
(stable) n= 18 B-3 8* -Benign
Suspicious micro-calcification n=2 
(progressed) B-4 Cancer
N=55 3rd follow-up  
Masses/asymmetrical                    B-2 Routine 1 year
density (stable) n= 45 follow-up
Suspicious micro-calcifications B-2 Routine 1 year
(stable) n= 10 follow-up
*= biopsy performed on referring physician or patient request.
number of unnecessary or negative biopsies in the
western world. This category is used for lesions that are
not definitely benign according to current standards.16
Recommending biopsies in all non-palpable lesions
detected on mammograms, increases cost and anxiety
to patient. This can be reduced by decreasing the
number of biopsy procedures and instead, performing
short-term mammographic follow-up.
Localization biopsy is not a procedure devoid of
complications, and there remains a 2-5% rate of failure
in surgically removing the abnormality.1
Sickles 8 reported cancer development in 0.5% of
patients after a 3-3.5 years minimum follow-up period. In
this study, the incidence of development of cancer was
3%, for an interval observation period of 12-18 months.
Forty one (43.96%) patients lost to follow-up were
excluded from the study. This compliance rate of only
56.04% shows that patients or physician compliance
is a major limitation of recommending follow-up.
Compliance rate of 88% has been reported from
Western world.6 The lower compliance rate in this study
is likely to be due to cost factor and lack of education
and awareness regarding breast cancer in the local
population of patients.
In this study of 65 patients who underwent follow-up,
3% demonstrated a biopsy proven cancer whereas
Varas has reported a rate of 1.7%.1 This is probably due
to small sample size. The sensitivity, specificity and
negative predictive values of this study are similar to that
of Vizcaino et al., who reported a sensitivity, specificity
and negative predictive values of 100%, 99% and 100%
respectively.17 Still, the availability of the non-complaint
group could have changed the present results.
The overall biopsy yield (29%) was higher than that of
Sickles8 (11%), Helvie et al.6 (10%) and Masroor18 (5%)
but lower than that of Varas et al.1 (56%). All biopsies
performed for lesion progression (2 of 10) were because
of changes in micro-calcification regarding number and
appearance on short-term follow-up. Both turn out to be
malignant. That was slightly less than reported by
Vizcaino et al.17 who found a cancer yield of 20% with
micro-calcifications, which progressed. In all other
lesions, biopsy was performed on either referring
physician’s or patient’s request. When a referring
physician is requesting, it is usually either because of
strong family history of breast cancer in patient, or any
other associated risk factor. Some women prefer
surgical biopsy rather than  living with uncertainty of
having a potentially malignant lesion with low probability.
In this study, where the rate of adherence to follow-up
was 56.04%, some cancer cases may have been lost or
conversely, a number of benign stable cases may have
been lost, affecting the over all results. Follow-up
compliance in assessment of category-3 lesions
remains a significant problem. The numbers lost to
follow up might have materially affected the computed
values. This factor was, however, beyond control.
CONCLUSION
In conclusion, assessment with short-term interval
mammographic follow-up is useful to confirm the benign
nature of most non-palpable, probably benign, breast
lesions and permits detection of a small number of
breast cancers at an early stage. In the local setup,
patient compliance is a major limitation for performing a
follow-up study, as almost half of patients do not turn-up
for follow-up mammography because of lack of
awareness and cost factor.
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